![](https://www.microbiometimes.com/wp-content/uploads/2019/11/shutterstock_1395291461-326x245.jpg)
Caelus Health and Nestlé Health Science sign exclusive global development & option agreement
Caelus Health, which develops food supplements and pharmaceutical products for the prevention, early treatment and management of cardio-metabolic diseases, is entering into a strategic collaboration with Nestlé Health Science (NHSc). The aim is to further […]